Profile data is unavailable for this security.
About the company
YSB Inc is an investment holding company mainly engaged in the provision of wholesale and retail of pharmaceuticals and healthcare products, as well as the provision of platform business services. The Company is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The Company provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The Company also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The Company principally conducts its businesses in the domestic market.
- Revenue in HKD (TTM)18.35bn
- Net income in HKD-3.45bn
- Incorporated2015
- Employees6.31k
- LocationYSB IncGUANGZHOU ChinaCHN
- Websitehttps://www.ysbang.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VITAL KSK HOLDINGS INC | 29.20bn | 290.41m | 3.50bn | 3.72k | 11.77 | 0.6503 | 9.36 | 0.1198 | 115.20 | 115.20 | 11,565.04 | 2,085.08 | 1.91 | 17.32 | 4.97 | -- | 1.93 | 1.40 | 4.95 | 3.48 | 8.22 | 7.76 | 1.01 | 0.7664 | 0.8887 | -- | 0.0858 | 34.75 | 1.33 | 0.9731 | 20.95 | 2.82 | 18.96 | 16.00 |
| Adcock Ingram Holdings Limited | 3.82bn | 363.29m | 3.81bn | 2.39k | 10.34 | 1.57 | -- | 0.996 | 5.49 | 5.49 | 57.72 | 36.26 | 1.12 | 2.52 | 4.38 | -- | 10.68 | 10.50 | 14.81 | 14.90 | 34.32 | 32.38 | 9.51 | 9.34 | 0.9352 | -- | 0.0806 | 40.35 | 4.89 | 7.43 | 12.25 | 7.45 | -7.92 | 7.77 |
| Shanghai New World Co Ltd | 1.24bn | 36.27m | 4.21bn | 1.20k | 116.14 | 0.9279 | -- | 3.41 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| YSB Inc | 18.35bn | -3.45bn | 5.05bn | 6.31k | -- | 2.43 | -- | 0.2753 | -25.65 | -25.65 | 47.52 | 3.24 | -- | -- | -- | 2,909,354.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Nu Skin Enterprises, Inc. | 14.89bn | -25.91m | 5.18bn | 3.70k | -- | 0.8189 | 9.60 | 0.3481 | -0.0758 | -0.0758 | 37.80 | 16.30 | 1.07 | 1.90 | 29.99 | 514,858.10 | -0.1858 | 6.80 | -0.2298 | 8.90 | 68.42 | 73.45 | -0.174 | 5.26 | 1.24 | 7.94 | 0.3736 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| Uniphar PLC | 21.64bn | 379.94m | 6.04bn | 3.26k | 15.90 | 2.14 | 8.85 | 0.2791 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| NanJing Pharmaceutical Co Ltd | 57.72bn | 634.59m | 6.71bn | 4.90k | 10.50 | 0.9319 | -- | 0.1162 | 0.4513 | 0.4513 | 41.07 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Holder | Shares | % Held |
|---|---|---|
| Tiger Global Management LLCas of 30 Jun 2023 | 80.00m | 12.48% |
| Krane Funds Advisors LLCas of 09 May 2024 | 12.87m | 2.01% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 6.94m | 1.08% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023 | 899.20k | 0.14% |
| E Fund Asset Management Co. Ltd.as of 31 Dec 2023 | 635.80k | 0.10% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 404.40k | 0.06% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 31 Dec 2023 | 399.40k | 0.06% |
| China Asset Management (Hong Kong) Ltd.as of 30 Apr 2024 | 220.09k | 0.03% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 149.60k | 0.02% |
| Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 100.80k | 0.02% |
